Filter
607
Text search:
pipeline
Featured
Recommendations
69
New Publications
155
Language
Document type
No document type
255
Studies & Reports
133
Guidelines
84
Strategic & Response Plan
44
Manuals
41
Situation Updates
18
Fact sheets
14
Resource Platforms
5
Training Material
4
Infographics
3
Videos
3
Online Courses
2
Brochures
1
Countries / Regions
Global
36
South Sudan
16
Kenya
15
Ethiopia
14
India
14
Syria
13
South Africa
13
Africa
13
Ukraine
12
Nigeria
11
Mozambique
10
Sierra Leone
9
Uganda
9
East and Southern Africa
9
Nepal
8
Rwanda
8
Liberia
7
Haiti
7
Myanmar / Burma
7
Zambia
6
Bangladesh
6
Malawi
6
Yemen
6
Latin America and the Carribbean
6
Tanzania
5
West and Central Africa
5
China
4
Asia
4
Guinea
3
Congo, Democratic Republic of
3
USA
3
Philippines
3
Sudan
3
South–East Asia Region
3
Eastern Europe
3
Burkina Faso
2
Jordan
2
Turkey
2
Indonesia
2
Central African Republic
2
Brazil
2
Burundi
2
Botswana
2
Western and Central Europe
2
Albania
2
Russia
2
Moldova
2
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Ghana
1
Zimbabwe
1
Somalia
1
Pakistan
1
Thailand
1
Singapore
1
Benin
1
Namibia
1
Eswatini/ Swaziland
1
Serbia
1
Hungary
1
Colombia
1
Ecuador
1
Angola
1
Sri Lanka
1
Middle East and North Africa
1
Western Pacific Region
1
Bhutan
1
Venezuela
1
Poland
1
Italy
1
Southern Africa
1
Laos
1
Qatar
1
Romania
1
Vietnam
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
181
Clinical Guidelines
40
Key Resources
40
Pharmacy & Technologies
29
Public Health
17
Women & Child Health
12
Capacity Building
3
Annual Report MEDBOX
1
Toolboxes
COVID-19
77
AMR
71
TB
50
HIV
47
Conflict
42
NTDs
28
Natural Hazards
23
Malaria
20
Health Financing Toolbox
18
Planetary Health
16
Pharmacy
11
Ebola & Marburg
10
Mental Health
7
Specific Hazards
7
Rapid Response
4
Global Health Education
4
Caregiver
4
Cholera
3
Refugee
3
Zika
3
Disability
2
Typhoon
2
2.0 Rapid Response
2
Polio
1
Social Ethics
1
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
3 March 2016
Many in-house and commercial assays that detect the COVID-19 virus have been developed or are currently under development. Many of these molecular assays are currently being validated in partner laboratories. An overview of assays that have applied to FIND for participation in their assay assessment
...
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they progress through the development pipeline. We will update it weekly. An overview of the different vac
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spr
...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. Th
...
29 April 2022
What are the new vaccines in the pipeline? What are the challenges to turning vaccines into vaccination ? What timelines can we expect for future vaccines? WHO’s Dr Katherine O’Brien explains in Science in 5.
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
How do vaccines work to protect us? What are the vaccine technologies in the pipeline and how do we ensure safe vaccines? Dr Katherine O’ Brien explains in Science in 5 !
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the Global Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are
...
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of CO
...
Accessed on 22.04.2023
To target helminth elimination, a new consortium of research institutes, universities, not-for-profit organizations, and pharmaceutical companies have joined forces and expertise to establish a research and development pipeline
...
Overuse and misuse of antibiotics in animals and humans is contributing to the rising threat of antibiotic resistance. Some types of bacteria that cause serious infections in humans have already developed resistance to most or all of the available treatments, and there are very
...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form
...
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of point-of-care diagnostic technologies for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vagi
...
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmented approaches and short-term planning pose considera
...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. It is a significant public health problem, affecting millions of people worldwide. And although it was described 110 years ago, only two old nitroheterocyclic drugs, benznidazole and nifurtimox, are cu
...
